| molecular function |
|---|
| | GO:0042054 | | histone methyltransferase activity | | Catalysis of the reaction: S-adenosyl-L-methionine + histone = S-adenosyl-L-homocysteine + methyl-histone. Histone methylation generally occurs on either an arginine or lysine residue. |
| | GO:0035642 | | histone methyltransferase activity (H3-R17 specific) | | Catalysis of the reaction: S-adenosyl-L-methionine + (histone H3)-arginine (position 17) = S-adenosyl-L-homocysteine + (histone H3)-N-methyl-arginine (position 17). This reaction is the addition of a methyl group to arginine at position 17 of histone H3. |
| | GO:0008469 | | histone-arginine N-methyltransferase activity | | Catalysis of the reaction: S-adenosyl-L-methionine + (histone)-arginine = S-adenosyl-L-homocysteine + (histone)-N-methyl-arginine. |
| | GO:0030374 | | ligand-dependent nuclear receptor transcription coactivator activity | | The function of a transcription cofactor that activates transcription in conjuction with a ligand-dependent nuclear receptor from a RNA polymerase II promoter; does not bind DNA itself. |
| | GO:0070577 | | lysine-acetylated histone binding | | Interacting selectively and non-covalently with a histone in which a lysine residue has been modified by acetylation. |
| | GO:0008168 | | methyltransferase activity | | Catalysis of the transfer of a methyl group to an acceptor molecule. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| | GO:0008276 | | protein methyltransferase activity | | Catalysis of the transfer of a methyl group (CH3-) to a protein. |
| | GO:0016274 | | protein-arginine N-methyltransferase activity | | Catalysis of the reaction: S-adenosyl-L-methionine + (protein)-arginine = S-adenosyl-L-homocysteine + (protein)-N-methyl-arginine. |
| | GO:0035242 | | protein-arginine omega-N asymmetric methyltransferase activity | | Catalysis of the addition of a second methyl group to methylated peptidyl-arginine. Methylation is on the same terminal nitrogen (omega nitrogen) residue that was previously methylated, resulting in asymmetrical peptidyl-N(omega),N(omega)-dimethylated arginine residues. |
| | GO:0003713 | | transcription coactivator activity | | Interacting selectively and non-covalently with a activating transcription factor and also with the basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. |
| | GO:0044212 | | transcription regulatory region DNA binding | | Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
| | GO:0016740 | | transferase activity | | Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2. |
| biological process |
|---|
| | GO:0008380 | | RNA splicing | | The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA. |
| | GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| | GO:0060350 | | endochondral bone morphogenesis | | The process in which bones are generated and organized as a result of the conversion of initial cartilaginous anlage into bone. |
| | GO:0034971 | | histone H3-R17 methylation | | The modification of histone H3 by addition of a methyl group to arginine at position 17 of the histone. |
| | GO:0034970 | | histone H3-R2 methylation | | The modification of histone H3 by addition of a methyl group to arginine at position 2 of the histone. |
| | GO:0034969 | | histone arginine methylation | | The modification of a histone by addition of a methyl group to an arginine residue. |
| | GO:0016571 | | histone methylation | | The modification of histones by addition of methyl groups. |
| | GO:0030520 | | intracellular estrogen receptor signaling pathway | | Any series of molecular signals generated as a consequence of an intracellular estrogen receptor binding to one of its physiological ligands. The pathway begins with receptor-ligand binding, and ends with regulation of a downstream cellular process (e.g. transcription). |
| | GO:0030518 | | intracellular steroid hormone receptor signaling pathway | | A series of molecular signals generated as a consequence of a intracellular steroid hormone receptor binding to one of its physiological ligands. |
| | GO:0006397 | | mRNA processing | | Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide. |
| | GO:0032259 | | methylation | | The process in which a methyl group is covalently attached to a molecule. |
| | GO:2000171 | | negative regulation of dendrite development | | Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development. |
| | GO:0032091 | | negative regulation of protein binding | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
| | GO:0035246 | | peptidyl-arginine N-methylation | | The addition of a methyl group onto a nitrogen atom of an arginine residue in a protein. |
| | GO:0019919 | | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | | The process of methylation of peptidyl-arginine to form peptidyl-N(omega),N(omega)-dimethyl-L-arginine. |
| | GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| | GO:0045600 | | positive regulation of fat cell differentiation | | Any process that activates or increases the frequency, rate or extent of adipocyte differentiation. |
| | GO:0006479 | | protein methylation | | The addition of a methyl group to a protein amino acid. A methyl group is derived from methane by the removal of a hydrogen atom. |
| | GO:0003420 | | regulation of growth plate cartilage chondrocyte proliferation | | Any process that modulates the rate, frequency, or extent of the multiplication or reproduction of chondrocytes in a growing endochondral bone, resulting in the expansion of a cell population. |
| | GO:0033146 | | regulation of intracellular estrogen receptor signaling pathway | | Any process that modulates the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway. |
| | GO:1902415 | | regulation of mRNA binding | | Any process that modulates the frequency, rate or extent of mRNA binding. |
| | GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0051591 | | response to cAMP | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
| | GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
| cellular component |
|---|
| | GO:0090575 | | RNA polymerase II transcription factor complex | | A transcription factor complex that acts at promoters of genes transcribed by RNA polymerase II. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
Description
